Stock Earnings An Analysis of X4 Pharmaceuticals Inc (XFOR)’s Potential Price Growth X4 Pharmaceuticals Inc’s recent filing unveils that its Chief Commercial Officer Baldry Mark acquired Company’s shares for reported $2561.0 on
Insiders Updates Checking in on X4 Pharmaceuticals Inc (XFOR) after recent insiders movement X4 Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Baldry Mark acquired Company’s shares for reported $2561.0 on
Analysts Viewpoint X4 Pharmaceuticals Inc [XFOR] Investment Appeal on the Rise In a filing, X4 Pharmaceuticals Inc revealed its Chief Commercial Officer Baldry Mark acquired Company’s shares for reported $2561.0 on
X4 Pharmaceuticals Inc. (NASDAQ: XFOR) Gets A 80.4% Target Price Upside From Analysts While 50.75% Above Its 52-Week Low X4 Pharmaceuticals Inc. (NASDAQ:XFOR) does about 1.33M shares in volume on a normal day but saw 423127 shares change hands